BC Partners is acquiring control of PetLab Co., a London-headquartered independent pet supplement brand. The target is positioned in pet supplements and is based in London.
The transaction is structured as BC Partners acquiring a majority stake in PetLab Co. The disclosed economics center on control rather than a full buyout, with the co-founders remaining invested alongside BC Partners.
Post-closing, PetLab Co.'s co-founders are set to retain a significant investment, indicating ongoing management and ownership continuity alongside BC Partners. That continuing stake is a notable feature of the deal's ownership structure.
PetLab Co. is the target in a control transaction in which it agreed to sell a majority stake, positioning the company as the seller-side business changing ownership.
A notable disclosed feature is that the transaction was announced on 2025-02-26 as a majority-stake sale to BC Partners, indicating post-signing ownership will shift to BC Partners as controlling investor.